THere needs to be efficiency gains in manufacturing. And maybe that's too much for a little company like MSB.
MSB has done a great job in proving the concept but they're perhaps ill equipped to take it to the next level where it needs to be.
OR.. they need to reduce costs down closer to $77 000 as a PR initiative to gain good will in the industry before going to make the mega bucks on CLBP and CHF.
Now that would be something the insurance companies would be happier to cover. Everybody is losing then. Except the sick kids - they're winning.
MSB Price at posting:
$2.56 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)